4.7 Review

Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC)

M. Pavic et al.

Summary: This study aims to investigate the impact of SBRT on pain control in patients with mPDAC by embedding MR-guided adaptive SBRT of the pPca in between standard chemotherapy cycles. A total of 92 eligible patients will be enrolled in a randomized controlled trial across 3 centers in Germany and Switzerland to evaluate the added benefit of MR-guided SBRT for pain control and prevention.

RADIATION ONCOLOGY (2022)

Article Chemistry, Medicinal

Repurposing of Auranofin Against Bacterial Infections: An In silico and In vitro Study

Nidhi Sharma et al.

Summary: The study demonstrated that auranofin has good antibacterial activity against both Gram positive and Gram negative bacterial strains, and showed synergistic or additive effects when used in combination with certain antibiotics. In vivo results indicated auranofin significantly decreased bioburden in the zebrafish infection model.

CURRENT COMPUTER-AIDED DRUG DESIGN (2021)

Article Environmental Sciences

Combined treatment with auranofin and trametinib induces synergistic apoptosis in breast cancer cells

Min-Kyung Joo et al.

Summary: The combination treatment of Auranofin and Trametinib showed synergistic effects on apoptosis in MCF-7 breast cancer cells by activating the p38 MAPK signaling pathway and mitochondrial apoptosis, leading to increased cancer cell death.

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2021)

Article Biochemistry & Molecular Biology

Ascorbate kills breast cancer cells by rewiring metabolism via redox imbalance and energy crisis

Ali Ghanem et al.

Summary: The use of high doses of ascorbate for cancer treatment has shown efficacy, particularly in inducing cytotoxicity against breast cancer cells through metabolic rewiring and disruption of cellular homeostasis. The mechanism of action involves oxidative stress, ROS accumulation, DNA damage, and altered metabolic pathways, leading to irreverisble cell death.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Article Oncology

Combination of Auranofin and ICG-001 Suppress the Proliferation and Metastasis of Colon Cancer

Zhaoyan Lin et al.

Summary: The combination therapy of AF and ICG-001 synergistically inhibits the growth and invasion of human colon cancer cells by inhibiting STAT3 phosphorylation and inducing apoptotic cell death. This combination also effectively suppresses the growth and metastasis of colon cancer in animal models, showing potential therapeutic properties for human colon cancer.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

Current status of non-surgical treatment of locally advanced pancreatic cancer

Stavros Spiliopoulos et al.

Summary: Pancreatic cancer ranks 7th in industrialized countries and 11th globally as a leading cause of cancer death. Despite advances in treatment options, the survival rate remains low due to the high percentage of unresectable cases.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate

Juan Du et al.

Summary: Pancreatic cancer cells are more susceptible to oxidative stress compared to normal cells, making them more sensitive to the cytotoxic effects of pharmacological ascorbate (P-AscH(-)). P-AscH(-) generates hydrogen peroxide fluxes that selectively kill PDACs without affecting normal cells. This treatment has been shown to sensitize PDACs to radiation while protecting normal cells, potentially through modulation of Nrf2, RelB, and cellular bioenergetics.

ANTIOXIDANTS (2021)

Article Oncology

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era

Joseph Abi Jaoude et al.

Summary: Comparison of clinical outcomes between SBRT and 3D/IMRT in pancreatic cancer patients showed no significant differences in overall survival and progression-free survival. Surgical resection was associated with better overall survival. Future prospective data are needed to further evaluate the role of SBRT in these patients.

ADVANCES IN RADIATION ONCOLOGY (2021)

Review Gastroenterology & Hepatology

Pancreatic cancer: A review of epidemiology, trend, and risk factors

Jian-Xiong Hu et al.

Summary: Pancreatic cancer remains highly lethal with low survival rates and difficulty in early detection. The incidence and mortality of pancreatic cancer are increasing worldwide, and understanding the risk factors is crucial for prevention.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Article Oncology

Phase I study of dose-escalated stereotactic body radiation therapy for locally advanced pancreatic head cancers: Initial clinical results

Shuiwang Qing et al.

Summary: The study aimed to establish the maximum tolerated dose (MTD) of stereotactic body radiation therapy (SBRT) for locally advanced pancreatic head cancers. Results showed that SBRT doses ranging from 35 to 45 Gy in five fractions could be effective, but attention should be paid to the side effect of biliary obstruction.

CANCER MEDICINE (2021)

Article Biochemistry & Molecular Biology

Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer

Laurie Freire Boullosa et al.

Summary: Auranofin (AF), an FDA-approved antirheumatic drug, exhibits anticancer properties by inhibiting TrxR in non-small cell lung cancer cells. Mutant p53 expression enhances sensitivity to AF and leads to various cell death mechanisms including apoptosis and ferroptosis. AF also modulates the innate immune response, enhancing natural killer cell-mediated killing and dendritic cell maturation.

REDOX BIOLOGY (2021)

Article Infectious Diseases

Repurposing auranofin as a Clostridioides difficile therapeutic

Melanie L. Hutton et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

Article Biochemistry & Molecular Biology

Comprehensive chemical proteomics for target deconvolution of the redox active drug auranofin

Amir Ata Saei et al.

REDOX BIOLOGY (2020)

Article Multidisciplinary Sciences

The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data

Axel Bengtsson et al.

SCIENTIFIC REPORTS (2020)

Article Oncology

Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer

Elie Hatem et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Article Oncology

Pancreatic Adenocarcinoma, Version 1.2019

Margaret A. Tempero et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)

Article Biochemistry & Molecular Biology

Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate

Agnieszka Graczyk-Jarzynka et al.

REDOX BIOLOGY (2019)

Article Environmental Sciences

Combination treatment with auranofin and nutlin-3a induces synergistic cytotoxicity in breast cancer cells

Dong-Jin Ye et al.

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2019)

Article Biology

Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer

Matthew S. Alexander et al.

RADIATION RESEARCH (2019)

Review Oncology

Targeting cancer vulnerabilities with high-dose vitamin C

Bryan Ngo et al.

NATURE REVIEWS CANCER (2019)

Article Biochemistry & Molecular Biology

A role for 2-Cys peroxiredoxins in facilitating cytosolic protein thiol oxidation

Sarah Stoecker et al.

NATURE CHEMICAL BIOLOGY (2018)

Review Biochemistry & Molecular Biology

The Conundrum of Hydrogen Peroxide Signaling and the Emerging Role of Peroxiredoxins as Redox Relay Hubs

Sarah Stoecker et al.

ANTIOXIDANTS & REDOX SIGNALING (2018)

Article Oncology

Auranofin Enhances Ibrutinib's Anticancer Activity in EGFR-Mutant Lung Adenocarcinoma

Jing Hu et al.

MOLECULAR CANCER THERAPEUTICS (2018)

Article Medicine, General & Internal

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

T. Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Medicine, General & Internal

Chemotherapy and radiotherapy for advanced pancreatic cancer

Venessa Chin et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)

Meeting Abstract Biochemistry & Molecular Biology

Inhibition of Peroxide Removal Enhances Pharmacological Ascorbate and Ionizing Radiation-Induced Cytotoxicity of Pancreatic Ductal Adenocarcinoma

Brianne O'Leary et al.

FREE RADICAL BIOLOGY AND MEDICINE (2017)

Article Oncology

Pancreatic Adenocarcinoma, Version 2.2017

Margaret A. Tempero et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)

Article Biochemistry & Molecular Biology

Oxidative Stress Promotes Peroxiredoxin Hyperoxidation and Attenuates Pro-survival Signaling in Aging Chondrocytes

John A. Collins et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Review Medicine, Research & Experimental

The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy

Michael Goldstein et al.

ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)

Article Oncology

Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer

Juan Du et al.

CANCER RESEARCH (2015)

Article Biochemistry & Molecular Biology

Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer

John A. Cieslak et al.

FREE RADICAL BIOLOGY AND MEDICINE (2015)

Article Gastroenterology & Hepatology

Progression-free survival as surrogate endpoint in advanced pancreatic cancer: meta-analysis of 30 randomized first-line trials

Fausto Petrelli et al.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2015)

Article Biochemistry & Molecular Biology

Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling

Mirko C. Sobotta et al.

NATURE CHEMICAL BIOLOGY (2015)

Review Biochemistry & Molecular Biology

The thioredoxin antioxidant system

Jun Lu et al.

FREE RADICAL BIOLOGY AND MEDICINE (2014)

Article Biochemistry & Molecular Biology

Inhibitors of hydroperoxide metabolism enhance ascorbate-induced cytotoxicity

K. E. Olney et al.

FREE RADICAL RESEARCH (2013)

Review Gastroenterology & Hepatology

Pancreatic cancer: why is it so hard to treat?

Paul E. Oberstein et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2013)

Review Biochemistry & Molecular Biology

Ascorbic acid: Chemistry, biology and the treatment of cancer

Juan Du et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)

Article Microbiology

Auranofin Protects against Anthrax Lethal Toxin-Induced Activation of the Nlrp1b Inflammasome

Zachary L. Newman et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)

Article Biochemistry & Molecular Biology

Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer

Michael Graham Espey et al.

FREE RADICAL BIOLOGY AND MEDICINE (2011)

Article Biochemistry & Molecular Biology

Model for the Exceptional Reactivity of Peroxiredoxins 2 and 3 with Hydrogen Peroxide A KINETIC AND COMPUTATIONAL STUDY

Peter Nagy et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Toxicology

Auranofin protects against cocaine-induced hepatic injury through induction of heme oxygenase-1

Takashi Ashino et al.

JOURNAL OF TOXICOLOGICAL SCIENCES (2011)

Article Medicine, General & Internal

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Gastroenterology & Hepatology

Practical approaches to effective management of intestinal radiation injury: Benefit of resectional surgery

Nikolaos Perrakis et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2011)

Article Biochemistry & Molecular Biology

Thioredoxin and thioredoxin reductase: Current research with special reference to human disease

Arne Holmgren et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)

Article Oncology

Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer

Juan Du et al.

CLINICAL CANCER RESEARCH (2010)

Article Biochemistry & Molecular Biology

Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects

Julien Verrax et al.

FREE RADICAL BIOLOGY AND MEDICINE (2009)

Review Biology

Current topics in DNA double-strand break repair

Junya Kobayashi et al.

JOURNAL OF RADIATION RESEARCH (2008)

Article Multidisciplinary Sciences

Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice

Qi Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Biochemistry & Molecular Biology

SVCT1 and SVCT2: key proteins for vitamin C uptake

I. Savini et al.

AMINO ACIDS (2008)

Article Multidisciplinary Sciences

Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo

Qi Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Biochemistry & Molecular Biology

Reactions of yeast thioredoxin peroxidases I and II with hydrogen peroxide and peroxynitrite: Rate constants by competitive kinetics

Renata Ogusucu et al.

FREE RADICAL BIOLOGY AND MEDICINE (2007)

Article Pharmacology & Pharmacy

The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukaemia HL-60 cells

SJ Park et al.

BRITISH JOURNAL OF PHARMACOLOGY (2005)

Article Multidisciplinary Sciences

Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues

Q Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Medicine, General & Internal

Vitamin C pharmacokinetics: Implications for oral and intravenous use

SJ Padayatty et al.

ANNALS OF INTERNAL MEDICINE (2004)

Article Biochemistry & Molecular Biology

Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria

TS Chang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Multidisciplinary Sciences

A new recommended dietary allowance of vitamin C for healthy young women

M Levine et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Review Biochemistry & Molecular Biology

Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple

FQ Schafer et al.

FREE RADICAL BIOLOGY AND MEDICINE (2001)

Article Multidisciplinary Sciences

Clustered DNA damages induced in isolated DNA and in human cells by low doses of ionizing radiation

BM Sutherland et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)